Komodo Health
1 2 3 4 5 6 7 8 9 10
CONTACT
1 2 3 4 5 6 7 8 9 10
CONTACT
WHY IT MATTERS

The inability to see patient, HCP/HCO, and payer dynamics in real time — and over time — impacts your ability to accurately assess disease epidemiology, patient characteristics, market size/share, and therapy effectiveness/outcomes, and to inform evidence-based medicine and access decisions.

CHALLENGE #2
Data Quality
02_Data_QLTY_Trophy_V2_1x_NoLoop-rotate

Only 14% of pharmaceutical companies report they are "extremely confident" in their data insights. Others report they are:

  • 39% "very confident"
  • 42% "confident"
  • 6% "somewhat confident"

What’s behind the challenge? 

  • Legacy aggregators pass along inherent data flaws to you, e.g., patient-token collisions and splits
  • Proprietary tokenization makes data linking extremely complex and problematic
  • The inability to surface crucial insights, e.g., care setting, dual-eligible populations, line-of-therapy, hospital chargemaster data, etc.
  • Point-in-time (stagnant) data cuts don’t capture recent clinical encounters
  • Without closed claims (longitudinal) data, you can't see the patient journey, HCP referrals, or intervention points to drive clinical trial recruitment or therapy adoption
WHY IT MATTERS RESOLVE THIS CHALLENGE
02_Data_QLTY_Trophy_V2_1x_NoLoop-rotate

Schedule
a Consultation

By filling out and submitting this form, you confirm that you agree to Komodo Health’s Terms of Service. For more information on how we process personal information, please refer to our published Privacy Notice.

check